WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998050344) SUBSTITUTED 3,3-DIAMINO-2-PROPENENITRILES, THEIR PREPARATION AND USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/050344    International Application No.:    PCT/DK1998/000176
Publication Date: 12.11.1998 International Filing Date: 06.05.1998
Chapter 2 Demand Filed:    26.11.1998    
IPC:
C07B 61/00 (2006.01), C07C 255/30 (2006.01), C07C 255/58 (2006.01), C07C 317/48 (2006.01), C07D 207/26 (2006.01), C07D 211/42 (2006.01), C07D 211/58 (2006.01), C07D 213/38 (2006.01), C07D 213/40 (2006.01), C07D 213/74 (2006.01), C07D 213/75 (2006.01), C07D 217/04 (2006.01), C07D 217/06 (2006.01), C07D 223/10 (2006.01), C07D 239/42 (2006.01), C07D 295/145 (2006.01), C07D 521/00 (2006.01)
Applicants: NOVO NORDISK A/S [DK/DK]; Novo Allé, DK-2880 Bagsværd (DK)
Inventors: DÖRWALD, Florenzio, Zaragoza; (DK).
HANSEN, John, Bondo; (DK)
Priority Data:
0533/97 07.05.1997 DK
Title (EN) SUBSTITUTED 3,3-DIAMINO-2-PROPENENITRILES, THEIR PREPARATION AND USE
(FR) 3,3-DIAMINO-2-PROPENENITRILES, PREPARATION ET UTILISATION DE CES DERNIERS
Abstract: front page image
(EN)Substituted cyanoenamines of general formula (I) wherein Z, R1, R2 and R3 are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
(FR)L'invention concerne des cyanoénamines selon la formule générale (I). Dans cette dernière, Z, R1, R2 et R3 sont tels que définis dans le descriptif. L'invention traite également de compositions de ces derniers et de procédés de préparation de ces composés. Ces composés permettent de traiter des maladies du système nerveux central, du système cardiovasculaire, du système pulmonaire, du système gastro-intestinal et du système endocrinonien.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)